Zubelewicz B - Search Results

1

Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin.

Brackowski R, Zubelewicz B, Romanowski W, Lissoni P, Barni S, Tancini G, Maestroni GJ. Brackowski R, et al. Among authors: zubelewicz b. J Biol Regul Homeost Agents. 1994 Jul-Sep;8(3):77-80. J Biol Regul Homeost Agents. 1994. PMID: 7754792 Clinical Trial.

2

A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients.

Lissoni P, Ardizzoia A, Barni S, Paolorossi F, Tancini G, Meregalli S, Esposti D, Zubelewicz B, Braczowski R. Lissoni P, et al. Among authors: zubelewicz b. Oncol Rep. 1995 Sep;2(5):871-3. doi: 10.3892/or.2.5.871. Oncol Rep. 1995. PMID: 21597833

3

Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin.

Lissoni P, Pittalis S, Ardizzoia A, Brivio F, Barni S, Tancini G, Pelizzoni F, Maestroni GJ, Zubelewicz B, Braczkowski R. Lissoni P, et al. Among authors: zubelewicz b. Support Care Cancer. 1996 Jul;4(4):313-6. doi: 10.1007/BF01358887. Support Care Cancer. 1996. PMID: 8829312 Clinical Trial.

4

Is there a role for melatonin in the treatment of neoplastic cachexia?

Lissoni P, Paolorossi F, Tancini G, Barni S, Ardizzoia A, Brivio F, Zubelewicz B, Chatikhine V. Lissoni P, et al. Among authors: zubelewicz b. Eur J Cancer. 1996 Jul;32A(8):1340-3. doi: 10.1016/0959-8049(96)00136-0. Eur J Cancer. 1996. PMID: 8869096 Clinical Trial.

5

Circadian fluctuations of melatonin, tumor necrosis factor-alpha and its soluble receptors in the circulation of patients with advanced gastrointestinal cancer.

Muc-Wierzgon M, Nowakowska-Zajdel E, Zubelewicz B, Wierzgon J, Kokot T, Klakla K, Szkilnik R, Wiczkowski A. Muc-Wierzgon M, et al. Among authors: zubelewicz b. J Exp Clin Cancer Res. 2003 Jun;22(2):171-8. J Exp Clin Cancer Res. 2003. PMID: 12866566

6

Genetic disregulation of gene coding tumor necrosis factor alpha receptors (TNF alpha Rs) in follicular thyroid cancer--preliminary report.

Zubelewicz B, Muc-Wierzgoń M, Wierzgoń J, Romanowski W, Mazurek U, Wilczok T, Podwinska E. Zubelewicz B, et al. J Biol Regul Homeost Agents. 2002 Apr-Jun;16(2):98-104. J Biol Regul Homeost Agents. 2002. PMID: 12144133

7

Decrease of erythropoietin level by human recombinant tumour necrosis factor alpha (hrec TNFalpha) in patients with advanced cancer.

Braczkowski R, Romanawsky W, Danikiewicz A, Muc-Wierzgon M, Błazelonis A, Zubelewicz B. Braczkowski R, et al. Among authors: zubelewicz b. J Biol Regul Homeost Agents. 2001 Oct-Dec;15(4):366-9. J Biol Regul Homeost Agents. 2001. PMID: 11860225

8

The estimation of endogenous tumor necrosis factor alpha and cortisol levels in serum in advanced neoplasm.

Baranowski M, Muc-Wierzgon M, Madej K, Wierzgoń J, Zubelewicz B. Baranowski M, et al. Among authors: zubelewicz b. J Exp Clin Cancer Res. 1999 Jun;18(2):241-5. J Exp Clin Cancer Res. 1999. PMID: 10464714

9

Transient increase of plasma interleukin-6 after infusion of recombinant tumor necrosis factor alpha in advanced cancer patients.

Zubelewicz B, Romanowski W, Braczkowska B, Lissoni P, Braczkowski R. Zubelewicz B, et al. J Exp Clin Cancer Res. 1998 Dec;17(4):449-52. J Exp Clin Cancer Res. 1998. PMID: 10089067

10

[Influence of treatment using recombinant tumor necrosis factor alpha (hrec TNF alpha) on circadian rhythm of cortisol secretion in patients with advanced neoplastic disease].

Zubelewicz B, Braczkowski R, Romanowski W, Grzeszczak W. Zubelewicz B, et al. Pol Arch Med Wewn. 1995 Dec;94(6):506-11. Pol Arch Med Wewn. 1995. PMID: 8618813 Polish.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results